HOME › DRUGS › NALTREXONE;BUPROPION
ACTIVE SUBSTANCE / INN

NALTREXONE;BUPROPION

Brand name(s): Mysimba
EMA LISTED
AUTHORISED
Obesity;Overweight
ACTIVE SUBSTANCE
Naltrexone;Bupropion
REGULATORS
EMA
SPONSORS / MAH
Orexigen Therapeutics Ireland Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
MysimbaOrexigen Therapeutics Ireland LimitedAuthorised26/03/2015Obesity;Overweight

FULL INTELLIGENCE ON NALTREXONE;BUPROPION

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →